[
  {
    "ts": "2026-02-19T12:22:00+00:00",
    "headline": "$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More",
    "summary": "Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene Therapy Tools and Reagents Market Cell & Gene Therapy Tools and Reagents Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"Cell and Gene Therapy Tools and Reagents: Global Markets\" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene therapy tools and reagents is",
    "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "9d5176e9-d523-318b-be9c-33f1e5f870c4",
      "content": {
        "id": "9d5176e9-d523-318b-be9c-33f1e5f870c4",
        "contentType": "STORY",
        "title": "$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More",
        "description": "",
        "summary": "Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene Therapy Tools and Reagents Market Cell & Gene Therapy Tools and Reagents Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"Cell and Gene Therapy Tools and Reagents: Global Markets\" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene therapy tools and reagents is",
        "pubDate": "2026-02-19T12:22:00Z",
        "displayTime": "2026-02-19T12:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Cell & Gene Therapy Tools and Reagents Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lCwnbT5CutkKQOCxNZL60Q--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yn.LMVeb3C8KN5SOS7qSFA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "SARTF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T16:05:00+00:00",
    "headline": "Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal",
    "summary": "MASI will be acquired by Danaher for $9.9B in cash, sending shares soaring as the medtech firm prepares to join DHR's Diagnostics segment.",
    "url": "https://finance.yahoo.com/news/masimos-board-backs-danahers-9-160500802.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "215a2f22-bf60-3a44-8501-f90aab156510",
      "content": {
        "id": "215a2f22-bf60-3a44-8501-f90aab156510",
        "contentType": "STORY",
        "title": "Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal",
        "description": "",
        "summary": "MASI will be acquired by Danaher for $9.9B in cash, sending shares soaring as the medtech firm prepares to join DHR's Diagnostics segment.",
        "pubDate": "2026-02-19T16:05:00Z",
        "displayTime": "2026-02-19T16:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/6ddc1ac8527dad9395e87db2ec9458d3",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QKCCdLL0KBMaEP.VndDSEg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6ddc1ac8527dad9395e87db2ec9458d3.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IyD8UmOeo9XOZyL5DDFooA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/6ddc1ac8527dad9395e87db2ec9458d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/masimos-board-backs-danahers-9-160500802.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/masimos-board-backs-danahers-9-160500802.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T04:40:08+00:00",
    "headline": "1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky",
    "summary": "Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.",
    "url": "https://finance.yahoo.com/news/1-wall-street-favorite-stock-044008570.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "4dbb75b5-9d66-3a30-b09c-f2a81f5e380e",
      "content": {
        "id": "4dbb75b5-9d66-3a30-b09c-f2a81f5e380e",
        "contentType": "STORY",
        "title": "1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky",
        "description": "",
        "summary": "Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.",
        "pubDate": "2026-02-19T04:40:08Z",
        "displayTime": "2026-02-19T04:40:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/24ecf1f1a47aa87f1ef6ba28b2caf0f0",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "MTN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hoBrSu_t5zizPr1c9mIc1Q--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/24ecf1f1a47aa87f1ef6ba28b2caf0f0.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jDzqpYGvOCudOTFh4MQ2dA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/24ecf1f1a47aa87f1ef6ba28b2caf0f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/1-wall-street-favorite-stock-044008570.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-wall-street-favorite-stock-044008570.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MT"
            },
            {
              "symbol": "MTN"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "CART"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]